Ruth Pettengell Selected Research

Ruth Pettengell Research Topics

Disease

19	Non-Hodgkin Lymphoma (Lymphosarcoma) 12/2021 - 04/2003
17	Neoplasms (Cancer) 01/2022 - 10/2002
15	Febrile Neutropenia 01/2021 - 12/2002
13	Neutropenia 12/2021 - 12/2002
12	Lymphoma (Lymphomas) 12/2021 - 04/2003
10	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 12/2021 - 01/2009
10	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 12/2021 - 04/2003
7	Breast Neoplasms (Breast Cancer) 01/2016 - 09/2006
5	Cardiotoxicity 07/2015 - 11/2009
4	Hodgkin Disease (Hodgkin's Disease) 04/2015 - 06/2005
4	Infections 12/2011 - 01/2009
2	COVID-19 01/2022 - 01/2020
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2021 - 10/2009
2	Frailty 01/2020 - 08/2019
2	Drug-Related Side Effects and Adverse Reactions 07/2015 - 01/2009
2	T-Cell Lymphoma (Lymphoma, T Cell) 12/2014 - 05/2011
2	Anemia 01/2013 - 05/2011
2	Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma) 05/2011 - 08/2009
2	Graft vs Host Disease (Graft-Versus-Host Disease) 10/2010 - 10/2002
1	Diarrhea 12/2021
1	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2021
1	Noninfiltrating Intraductal Carcinoma (DCIS) 08/2019
1	Glomerulonephritis 07/2019
1	Capillary Leak Syndrome 07/2019
1	Genetic Predisposition to Disease (Genetic Predisposition) 01/2018
1	Hypersensitivity (Allergy) 01/2018
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2017
1	Marginal Zone B-Cell Lymphoma (MALT Lymphoma) 06/2017
1	Common Variable Immunodeficiency 01/2017
1	Granuloma 01/2017
1	Pain (Aches) 01/2016
1	Lung Neoplasms (Lung Cancer) 01/2016
1	Asthenia 01/2016
1	Myalgia 01/2016
1	Heart Failure 07/2015
1	Unilateral Breast Neoplasms 07/2015
1	Disease Progression 04/2015
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 12/2014
1	B-Cell Lymphoma (Lymphoma, B Cell) 10/2014
1	Fever (Fevers) 06/2014

Drug/Important Bio-Agent (IBA)

20	Rituximab (Mabthera)FDA Link 12/2020 - 04/2003
10	Doxorubicin (Adriamycin)FDA LinkGeneric 04/2015 - 05/2006
9	pixantrone (BBR 2778)IBA 01/2020 - 11/2009
9	Cyclophosphamide (Cytoxan)FDA LinkGeneric 03/2014 - 05/2006
7	Vincristine (Oncovin)FDA LinkGeneric 01/2013 - 05/2006
5	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 01/2016 - 12/2002
5	AnthracyclinesIBA 07/2015 - 01/2009
5	Prednisolone (Predate)FDA LinkGeneric 01/2013 - 05/2008
4	pegfilgrastim (Neulasta)FDA Link 01/2021 - 12/2002
4	Filgrastim (Neupogen)FDA Link 07/2019 - 12/2002
4	Colony-Stimulating Factors (Colony Stimulating Factor)IBA 02/2015 - 10/2003
3	Gemcitabine FDA Link 01/2020 - 07/2012
3	Bleomycin (Blenoxane)FDA LinkGeneric 04/2015 - 11/2009
3	Vinblastine (Vinblastine Sulfate)FDA Link 04/2015 - 11/2009
3	Dacarbazine (DIC)FDA LinkGeneric 04/2015 - 11/2009
2	Hemoglobins (Hemoglobin)IBA 01/2021 - 05/2011
2	Transcription Factors (Transcription Factor)IBA 10/2017 - 06/2007
2	ibritumomab tiuxetan (Zevalin)FDA Link 04/2016 - 01/2014
2	Epirubicin (Ellence)FDA LinkGeneric 07/2015 - 03/2014
2	Docetaxel (Taxotere)FDA Link 02/2015 - 03/2014
2	Anti-Bacterial Agents (Antibiotics)IBA 06/2014 - 12/2002
2	AnthraquinonesIBA 07/2012 - 11/2009
2	Mitoxantrone (Novantrone)FDA LinkGeneric 07/2012 - 11/2009
2	Prednisone (Sone)FDA LinkGeneric 10/2011 - 05/2006
1	umbralisibIBA 12/2021
1	Transaminases (Aminotransferases)IBA 12/2021
1	Phosphatidylinositols (Phosphatidylinositol)IBA 12/2021
1	GalliumIBA 12/2020
1	obinutuzumabIBA 12/2020
1	Biological ProductsIBA 01/2020
1	idelalisibIBA 01/2018
1	Immunoglobulin G (IgG)IBA 01/2018
1	AllergensIBA 01/2018
1	IgE Receptors (Fc epsilon RI)IBA 01/2018
1	Immunoglobulin E (IgE)IBA 01/2018
1	AntibodiesIBA 01/2018
1	Protein Kinase CIBA 10/2017
1	Proteins (Proteins, Gene)FDA Link 10/2017
1	Indicators and Reagents (Reagents)IBA 10/2017
1	Chlorambucil (Leukeran)FDA Link 06/2017
1	CytokinesIBA 01/2017
1	Conditioned Culture MediaIBA 01/2017
1	Intravenous Immunoglobulins (IVIG)FDA Link 01/2017
1	Immunoglobulins (Immunoglobulin)IBA 01/2017
1	Pharmaceutical PreparationsIBA 01/2016
1	Aurora Kinase AIBA 12/2014
1	MLN 8237IBA 12/2014
1	Fluorouracil (Carac)FDA LinkGeneric 03/2014
1	Darbepoetin alfa (Aranesp)FDA Link 01/2013

Therapy/Procedure

33	Drug Therapy (Chemotherapy) 01/2022 - 12/2002
16	Therapeutics 01/2022 - 06/2007
6	Stem Cell Transplantation 01/2020 - 10/2002
4	Transplantation 05/2013 - 10/2002
3	Radiotherapy 08/2019 - 04/2015
3	Autologous Transplantation 05/2013 - 10/2002
2	Radioimmunotherapy 04/2016 - 01/2014
2	Salvage Therapy 07/2012 - 08/2010
2	Homologous Transplantation 10/2010 - 06/2005
1	Adjuvant Radiotherapy 08/2019
1	Immunotherapy 01/2018